This statistic depicts the private and public generic drug savings in Canada in 2023, by province. In the province of British Columbia, generic drug savings for private sector drug plans accumulated to around 63 million Canadian dollars, whereas the savings in public sector drug programs were around 31 million dollars.
| Characteristic | Public savings | Private savings |
|---|---|---|
| British Columbia | 30.9 | 62.7 |
| Alberta | 47 | 55 |
| Saskatchewan | 13 | 13.2 |
| Manitoba | 17.1 | 15.5 |
| Ontario | 182.8 | 227.1 |
| Quebec | 122 | 162.4 |
| New Brunswick | 10.1 | 18.1 |
| Nova Scotia | 11.8 | 19.9 |
| Newfoundland and Labrador/Prince Edward Island | 7.1 | 12.9 |
| Canada | 441.8 | 586.5 |
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Canadian pharmaceutical industry" in one document: edited and divided into chapters, including detailed references.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield
Vice President, Hearst Magazines
Global positioning
Key figures
Regional comparison
Products and prices
Therapy classes
Generics
Further related statistics
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
